With the recent published results of DESKTOP III, do you intend to change your practice of performing secondary cytoreductive surgery for recurrent, platinum-sensitive ovarian cancer?
https://pubmed.ncbi.nlm.nih.gov/34874631/
Community PollStarted
Do you intent to change your practice for performing secondary cytoreductive surgery in recurrent, platinum-sensitive ovarian cancer based on the results of DESKTOP III?
23 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Gynecologic Oncology · Center of Hope
Answered on
Since Dr. @Dr. First Last's 2018 long awaited ASCO presentation of the results of GOG-0213, I have taken pause before considering a patient for secondary cytoreductive surgery (CRS). Over the last decade, I have also performed less primary CRS and more neoadjuvant chemotherapy. The changes in my pra...
Join for free or sign in to see the full answer